Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

Clinical case report:

Chromosome Deletion

Impact of adaptive fun

Reduced brachial arter

Treatment satisfaction

See All (16) pages

Contact Us
If you have any questions or feedback please contact us.

Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes.

Shah VN, Dex T, Meneghini L, Rodrigues A, Polonsky WH. Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 May; 27(5):2523-2530.

View in: PubMed

subject areas

Adult
Aged
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 2
Female
Glucagon-Like Peptide-2 Receptor
Humans
Hypoglycemic Agents
Insulin Glargine
Male
Middle Aged
Patient Satisfaction
Peptides
Treatment Outcome

authors with profiles

Viralkumar N Shah

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium